CD14 monocyte PD-L1 and VEGF-A reductions are associated with improved survival after sintilimab plus DOX in advanced gastric cancer
- DOI
- 10.5414/cp205039
- Published
- 2026-11-09
- Container
- Int. Journal of Clinical Pharmacology and Therapeutics
- Publisher
- Dustri-Verlag Dr. Karl Feistle
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.5414/cp205039,
title = {CD14 monocyte PD-L1 and VEGF-A reductions are associated with improved survival after sintilimab plus DOX in advanced gastric cancer},
author = {Dongdong Wang and Guozhi Zhou},
year = {2026},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
doi = {10.5414/cp205039},
url = {https://doi.org/10.5414/cp205039}
}RIS
TY - JOUR TI - CD14 monocyte PD-L1 and VEGF-A reductions are associated with improved survival after sintilimab plus DOX in advanced gastric cancer AU - Dongdong Wang AU - Guozhi Zhou PY - 2026 JO - Int. Journal of Clinical Pharmacology and Therapeutics DO - 10.5414/cp205039 UR - https://doi.org/10.5414/cp205039 ER -
APA
Wang, D., & Zhou, G. (2026). CD14 monocyte PD-L1 and VEGF-A reductions are associated with improved survival after sintilimab plus DOX in advanced gastric cancer. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp205039
Source records
- crossref · retrieved 2026-11-10T07:22:47.900Z